On-Demand Video Session
Recorded from 2017 Western Pharmacy Exchange
Jennifer Gibson, PharmD, Excalibur Scientific, LLC
Pharmacists must remain up-to-date on all new drug approvals and withdrawals each year. Many unique and important medications were approved in 2016, and this module will describe newly approved agents in several therapeutic categories. Focus will be given to the most common drugs that pharmacists are likely to encounter in practice. The indications, dosing guidelines, adverse effects, and safety information will be discussed. Changes to existing drug formulations, indications, and labeling, as well as laws and regulations affecting patient care and pharmacy practice, will also be presented.
At the completion of this activity, the participant will be able to:
Continuing Pharmacy Education
The California Pharmacists Association (#0113) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. Upon completing an evaluation form, participants will be awarded 1.25 hours (0.125 CEUs) of Continuing Pharmacy Education Credit. A statement of credit will not be issued. Participants may log onto the CPE monitor website using their individual log in to download their statement of credit. Please allow 4 weeks for processing of CPE credits to the CPE monitor. UAN: 0113-0000-17-005-H04-P, 0113-0000-17-005-H04-T
Activity Type: Knowledge-based
Target Audience: Pharmacists and Technicians in all practice settings
Release Date: 1/5/2017
Expiration Date: 1/5/2020
CPhA Member – $49
Non-member – $99
|2017 Western Pharmacy Exchange Bundle Deal: $300
This session is one of 11 sessions in the bundle deal.
Purchase Bundle >